Persistence of antibodies to the Salmonella typhi Vi capsular polysaccharide vaccine in South African school children ten years after immunization

By Keddy K.H.   Klugman K.P.   Hansford C.F.   Blondeau C.   Bouveret le Cam N.N.  

Vaccine, Vol. 17, Iss. 2, 1999-01 ,pp. : 110-113

Elsevier

Access to resources Recommend Favorite

Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization

By Klugman K.P.   Koornhof H.J.   Robbins J.B.   Le Cam N.N.  

Vaccine, Vol. 14, Iss. 5, 1996-04 ,pp. : 435-438

Elsevier

Access to resources Recommend Favorite

Efficacy of Vi polysaccharide vaccine against strains of Salmonella typhi: reply

By Keddy K.H.   Klugman K.P.   Robbins J.B.  

Vaccine, Vol. 16, Iss. 9, 1998-05 ,pp. : 871-872

Elsevier

Access to resources Recommend Favorite

Immunogenicity of a new Salmonella Typhi Vi polysaccharide vaccine-vax-TyVi ( R)-in Cuban school children and teenagers

By Azze R.F.O.   Rodrguez J.C.M.   Iniesta M.G.   Marchena X.R.F.   Alfonso V.M.R.   Padron F.T.S.  

Vaccine, Vol. 21, Iss. 21, 2003-06 ,pp. : 2758-2760

Elsevier

Access to resources Recommend Favorite

Efficacy of Salmonella typhi Vi capsular polysaccharide vaccine in South Africa

By Wandel G.  

Vaccine, Vol. 15, Iss. 17, 1997-12 ,pp. : 1815-1815

Elsevier

Access to resources Recommend Favorite